Phase 3 Readout~month

Phase 3 Topline: Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers

Indication
Type 2 Diabetes

Other upcoming events for DSGN

Phase 3 ReadoutPhase 3 Topline: Explore the Relationship Between Single Nucleotide Polymorphisms and Topotecan Response and Toxicity
Phase 3 ReadoutPhase 3 Topline: Explore the Relationship Between Single Nucleotide Polymorphisms and Etoposide Response and Toxicity
Phase 3 ReadoutPhase 3 Topline: Explore the Relationship Between Single Nucleotide Polymorphisms and Raloxifene Response and Toxicit
Phase 3 ReadoutPhase 3 Topline: Explore the Relationship Between Single Nucleotide Polymorphisms and Alectinib Response and Toxicity

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers — DSGN Phase 3 Readout | BioSniper